Normal subjects (n = 9) | SARS patients (n = 12) | |
---|---|---|
CXCL10/IP-10 (pg/ml) | 95.8 ± 25.7 | 133.1 ± 37.5 |
CXCL9/MIG (pg/ml) | 20.2 ± 6.5 | 53.1 ± 14.1* |
IL-8 (pg/ml) | 1.5 ± 0.2 | 6.3 ± 1.0** |
CCL2/MCP-1 (pg/ml) | 2.4 ± 0.8 | 9.0 ± 1.2** |
CCL5/RANTES (pg/ml) | 1.0 ± 0.4 | 34.6 ± 9.3** |
TNF-α (pg/ml) | 0.004 ± 0.002 | 1.1 ± 0.3* |
IL-1β (pg/ml) | 0.00 ± 0.00 | 2.5 ± 1.8 |
IL-6 (pg/ml) | 0.001 ± 0.001 | 1.7 ± 0.5** |
IFN-γ (pg/ml) | 0.0 ± 0.0 | 0.4 ± 0.3 |
IL-2 (pg/ml) | 0.00 ± 0.00 | 0.4 ± 0.2 |
TGF-β (pg/ml) | 9.6 ± 2.9 | 15.4 ± 4.6 |
IGF-1 (ng/ml) | 0.06 ± 0.03 | 0.07 ± 0.05 |
EGF (pg/ml) | 0.0 ± 0.0 | 0.0 ± 0.0 |